PP
CALA

Paloma Partners’s Calithera Biosciences, Inc CALA Stock Holding History

Paloma Partners’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,000
Closed -$80K – 2035
2018
Q4 		$80K Buy
+1,000
New +$98.6K ﹤0.01% 1132
2017
Q2 		– Sell
-692
Closed -$160K – 2520
2017
Q1 		$160K Buy
+692
New +$120K ﹤0.01% 1885
2016
Q3 		– Sell
-2,017
Closed -$150K – 2223
2016
Q2 		$150K Buy
+2,017
New +$202K ﹤0.01% 2021

Other funds holding CALA

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Paloma Partners's CALA Position: Q1 2019 in Review

Paloma Partners sold out of Calithera Biosciences, Inc (CALA) in Q1 2019, closing a stake of 1,000 shares — an estimated $80K sold.

Paloma Partners first reported a position in CALA in Q2 2016 and held it in 3 quarters. The position peaked at $160K in Q1 2017. 71 funds tracked by Wall St. Rank hold CALA as of Q1 2019.

  • Paloma Partners reported no remaining Calithera Biosciences, Inc position as of Q1 2019 after selling out during the quarter.
  • Paloma Partners sold 1,000 Calithera Biosciences, Inc shares in Q1 2019, an estimated $80K.
  • Paloma Partners first reported a position in Calithera Biosciences, Inc in Q2 2016 and held it in 3 quarters.
  • Paloma Partners's Calithera Biosciences, Inc position peaked at $160K in Q1 2017.
  • 71 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2019.

Based on Paloma Partners's 13F filing for Q1 2019, filed 15 May 2019.